Speaker illustration

Doctor Yevgeniy Khariton

St. Luke's Mid America Heart Institute, Kansas City (United States of America)

Association between sacubitril/valsartan initiation and health status outcomes in heart failure with reduced ejection fraction: findings from the CHAMP-HF registry

Event: Heart Failure 2018

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Late breaking trial IV - Registries


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb